MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy (EpimiRNA) Consortium

At a Glance
  • Status: Active Consortium
  • Year Launched: 2013
  • Initiating Organization: European Comission Seventh Framework Programme (FP7)
  • Initiator Type: Government
  • Disease focus:
  • Location: Europe


The MicroRNAs in the Pathogenesis, Treatment and Prevention of Epilepsy (EpimiRNA) consortium aims to understand molecular mechanisms and diagnostics and develop novel therapeutics for epilepsy. The consortium aims to apply recent scientific breakthroughs that identified a new family of molecules that affect brain cell structure and function, called microRNAs, to better understand medical products targeted to epilepsy.


EpimiRNA aims to better understand the role of miRNAs in the pathogenesis of epilepsy.

The main aims of the EpimiRNA consortium include:

Consortium History

Sept. 1, 2013 – Project Start Date

Structure & Governance

The consortium is composed of investigators that participate in several working groups. The technical working groups include:


Funded by the European Union under the 7th Framework Programme under grant agreement n° 602130.



Points of Contact

Prof David Henshall - Coordinator
Royal College of Surgeons in Ireland
123 St Stephens Green
Dublin 2
Phone: +353 14028629
Email: dhenshall@rcsi.ie

Sponsors & Partners

Royal College of Surgeons in Ireland

Philipps Universitat Marburg

Universitair Medisch Centrum Utrecht

University College London

University of Verona

Universitatsklinikum Erlangen

Duke University

University of Campinas

University of Aarhus/iNANO

University of Southern Denmark

Dixi Microtechniques

Cerbomed GmbH

Interna Technologies BV

Bicoll GmbH

BC Platforms


Last Updated: 04/22/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.